BRIEF-Highbridge Capital Management reports 5.3 pct passive stake in Protalix Biotherapeutics

* Highbridge Capital Management Reports 5.3 Pct passive

stake in Protalix Biotherapeutics Inc as of Dec. 13

Source text: (http://bit.ly/2ioIPpE)

Further company coverage:

Read more